ClinicalTrials.gg
Sign In

Endometrial Neoplasms clinical trials

The registry lists 1,425 studies for Endometrial Neoplasms across more than 10 countries. 473 are recruiting or about to start. 775 of them are mainly about Endometrial Neoplasms (how this is decided). Per ClinicalTrials.gov, last updated 2026-11-10. Counting its 2 narrower conditions too, such as Carcinoma, Endometrioid: 1,469 studies, 477 open.

ClinicalTrials.gov finds 1,664 studies for Endometrial Neoplasms. How that becomes 1,423 here

This page counts the studies the registry files under Endometrial Neoplasms, and those it files under no condition that list Endometrial Neoplasmsthemselves. Each study its search finds is placed by how the registry filed it and by the conditions it lists. ClinicalTrials.gov counts as of Nov 8, 2026. How condition pages count

  1. 1,664Found by its condition searchIt reads the conditions a study lists and their synonyms, and also titles and keywords.
  2. −36Filed under a narrower condition, counted on its own pageCarcinoma, Endometrioid 14 · Sarcoma, Endometrial Stromal 9
  3. −16List Endometrial Neoplasms as a condition, but the registry did not file them under itMost often written as “Advanced Endometrial Carcinoma” (2), “Early Stage Endometrial Cancer” (1), and “Microsatellite Instability (MSI)-High Endometrial Cancer” (1). The registry filed them under other conditions only, most often Ovarian Neoplasms (5) and Recurrence (4).
  4. −191Match it another way86 name it in the title, 2 in a keyword, and 103 by a synonym or other text the search reads.
  5. 1,421Counted here and found by its search26 of them list Endometrial Neoplasms in their own words; the registry filed them under no condition.
  6. +2
    Counted here, but its search does not find them
  7. 1,423The count on this page

Get an email when these change. Save the Endometrial Neoplasms studies recruiting or about to start — once a week, free: studies that open, close, add sites or post results.

Watch these studies
See an example email

Example · made-up studies

Breast cancer · Recruiting: 2 came in, 3 changed

What changed in your saved searches, Oct 31 – Nov 6:

A study of drug A after surgery for early breast cancer

Came in · now Recruiting

Drug B with hormone therapy in advanced breast cancer

Changed

· Sites: 4 added, including Seoul and Busan

· Enrollment: 300 → 450 participants

Exercise during chemotherapy

Now Active, not recruiting

One email a week for all your saved searches. Stop any time.

Status

Completed
522
Recruiting
359
Status unknown
146
Active, not recruiting
132
Not yet recruiting
107
Terminated
104

Phase

Phase 2
443
Phase 1
325
Phase 3
94
Early Phase 1
24
Phase 4
14

Where

United States
713
China
171
Italy
139
Spain
130
Canada
127
France
125

Who runs them

National Cancer Institute (NCI) (48) · M.D. Anderson Cancer Center (40) · Memorial Sloan Kettering Cancer Center (30) · Peking University People's Hospital (19) · Mayo Clinic (19) · Gynecologic Oncology Group (18) · UNC Lineberger Comprehensive Cancer Center (18) · Fondazione Policlinico Universitario Agostino Gemelli IRCCS (17)

What is being tested here

Drugs under test in Endometrial Neoplasms studies, those with the most open studies first. Medicines only given beside them are not counted. How drugs are counted

DrugOpenPhase 3All
Dostarlimab11317
Paclitaxel7538
Pembrolizumab5825
Letrozole5416
Abemaciclib507
Bevacizumab4116
Lenvatinib4315
Tirzepatide405
Carboplatin3325
Olaparib3311

Drug classes tested here Immune checkpoint inhibitors 42 open · Tyrosine kinase inhibitors (TKIs) 13 open · Antibody-drug conjugates (ADCs) 10 open · PARP inhibitors 9 open · Antimitotic agents 8 open

Coming up

47phase 3 studies under way
165studies finish main data collection within a year6 of them phase 3

Studies recruiting or running, from their records. “Main data collection” ends at the primary completion date, the sponsor’s own estimate, which often moves.

The 10 nearest, phase 3 first

Who these studies take

Of the 359 Endometrial Neoplasms studies recruiting now, 269 (75%) set no upper age limit and 54 (15%) stop at 75 or younger. 27 (8%) take children under 18. 222 (62%) are for women only and 0 (0%) for men only; 23 (6%) take healthy volunteers.

Recruiting studies that take each age, of 359
AgeWomenMen
1020 (6%)8 (2%)
18331 (92%)131 (36%)
30346 (96%)134 (37%)
40348 (97%)135 (38%)
50334 (93%)134 (37%)
65336 (94%)135 (38%)
75330 (92%)134 (37%)
85293 (82%)124 (35%)

Across all 1,425 studies, recruiting or not: 12% stop at 75 or younger and 5% at 65; 11% take children; 69% are for women only and 0% for men only; 8% take healthy volunteers. From each study’s registry entry; the criteria on its page decide.

How long Endometrial Neoplasms studies take

Of 139 phase 2 interventional studies under Endometrial Neoplasms, half reached primary completion within 55 months of starting, counting those still running.

Start to primary completionEvery sponsorIndustryNon-industry
Phase 161 mo46–79 · 130 studies54 mo45–69 · 88 studies67 mo53–80 · 42 studies
Phase 1/269 mo54–106 · 79 studies——
Phase 255 mo37–115 · 139 studies—60 mo40–115 · 107 studies
Phase 353 mo45–126 · 44 studies——
Interventional, no phase43 mo19–76 · 201 studies—44 mo20–76 · 195 studies
Observational105 mo32–207 · 150 studies—105 mo32–206 · 130 studies

Each figure is the month by which half the studies had reached primary completion, with the range in which the middle half did. Studies still running count until their last registry update; studies that stopped early are left out. Phase 1 includes early phase 1; observational means prospective or not stated, as retrospective and cross-sectional studies date a window of data rather than a study. How these figures are worked out

What changed recently

From the registry's own updates since Oct 13, 2026.

Started recruiting8

Show 3 more

Results posted3

Newly registered17

Show 12 more

Studies

Recruiting first, then most recently updated. Showing 50 of 1,425. Browse all 1,425 → or search them.